Showing results (261-270 of 388) with videos related to

Sort By:
Pageof 39
Acta Oncologica (Stockholm, Sweden)|September 9, 2017
Differential gene expression in primary fibroblasts induced by proton and cobalt-60 beam irradiationSteffen Nielsen, Niels Bassler, Leszek Grzanka, et al.
European Journal of Medical Genetics|July 17, 2022
Genetic testing in adult survivors of retinoblastoma in Denmark: A study of the experience and impact of genetic testing many years after initial diagnosisPernille A Gregersen, Mikkel Funding, Jan Alsner, et al.
BMJ Open Ophthalmology|September 27, 2021
Living with heritable retinoblastoma and the perceived role of regular follow-up at a retinoblastoma survivorship clinic: 'That is exactly what I have been missing'Pernille Axel Gregersen, Mikkel Funding, Jan Alsner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2014
Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA databaseCharlotte Rotbøl Bøje, Susanne O Dalton, Hanne Primdahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 15, 2025
A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure analyses outcomes in head and neck squamous cell carcinomaMorten Horsholt Kristensen, Signe Bergliot Nielsen, Jan Alsner, et al.
Acta Oncologica (Stockholm, Sweden)|August 7, 2015
External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohortMarianne F Rønjom, Carsten Brink, Søren M Bentzen, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2025
Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk dosesChristian Rønn Hansen, Anders S Bertelsen, Irene Hazell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2025
DAHANCA19: A randomized phase III study of primary curative (chemo)-radiotherapy and the EGFR-inhibitor zalutumumab for squamous cell carcinoma of the head and neckJesper Grau Eriksen, Christian Maare, Jørgen Johansen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancerHanna R Mortensen, Jens Overgaard, Lena Specht, et al.
Cancer Genetics and Cytogenetics|January 28, 2003
Allelic imbalance in selected chromosomal regions in ovarian cancerLise Lotte Hansen, Lise Lind Jensen, Constantine Dimitrakakis, et al.
Pageof 39